Monday, 13 March 2017

Volition (VNRX) reports FY earnings ahead of cancer drug launch: IG UK

Published on 13 Mar 2017
13 March 2017:  Volition (VNRX) reports its full year earnings as it readies itself to launch its blood test for bowel cancer across Europe. IG’s Jeremy Naylor talks to the CEO Cameron Reynolds.
at

No comments:

Post a Comment